Lixte Biotechnology (LIXTW) Stock Analysis

What Lixte Biotechnology does

Lixte Biotechnology Holdings, Inc. functions as a biopharmaceutical firm dedicated to the discovery and development of innovative therapeutic compounds. The company leverages advanced biomarker technology to create novel drug candidates aimed at combating severe and widespread human diseases. Its core research primarily concentrates on protein phosphatase inhibitors, which are being explored for standalone administration or in conjunction with cytotoxic agents, radiation therapy, and immune checkpoint blockers. The company's developmental pipeline includes two distinct series of pharmacologically active agents, both progressing through various preclinical and clinical phases. The LB-100 series comprises new chemical entities designed to address cancers, vascular ailments, and metabolic disorders. Meanwhile, the LB-200 series is being developed to treat chronic hereditary conditions, such as Gaucher's disease, alongside certain types of cancer and neurodegenerative illnesses. Lixte Biotechnology Holdings, Inc. maintains significant research collaborations, including a clinical trial agreement with the Moffitt Cancer Center and Research Institute Hospital Inc. It also has partnership agreements for investigator-initiated clinical trials with the Spanish Sarcoma Group, as well as the Netherlands Cancer Institute and Oncode Institute. Established in 2005, the company's headquarters are located in Pasadena, California.

Key metrics

ETFs linked to LIXTW

Broad-market and Healthcare sector ETFs an investor holding Lixte Biotechnology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LIXTW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Lixte Biotechnology?

Lixte Biotechnology trades under the ticker LIXTW on NASDAQ.

Which exchange is LIXTW listed on?

LIXTW is listed on NASDAQ.

What sector does Lixte Biotechnology operate in?

Lixte Biotechnology is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LIXTW in a portfolio?

PortView shows LIXTW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.